James Shin
Stock Analyst at Deutsche Bank
(0.54)
# 3,559
Out of 4,829 analysts
20
Total ratings
n/a
Success rate
-1.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $103.82 | +15.58% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $80.43 | +30.55% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $755.57 | +34.34% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $274.76 | +11.01% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $60.85 | -1.40% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $48.18 | -6.60% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $32.38 | +85.30% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $190.07 | -21.08% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $575.63 | +38.98% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $1.35 | +640.74% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.87 | +1,279.31% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $0.69 | +10,001.01% | 1 | Dec 12, 2022 |
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $103.82
Upside: +15.58%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $80.43
Upside: +30.55%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $755.57
Upside: +34.34%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $274.76
Upside: +11.01%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $60.85
Upside: -1.40%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $48.18
Upside: -6.60%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $32.38
Upside: +85.30%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $190.07
Upside: -21.08%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $575.63
Upside: +38.98%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.87
Upside: +1,279.31%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $0.69
Upside: +10,001.01%